News and Events

card-img

Trazher 150 mg Powder for Concentrate for Solution for Infusion is approved in Singapore

On 19 Oct 2022, Trazher 150 mg Powder for Concentrate for...

READ MORE
card-img

Indonesia's FDA (BPOM) has approved new indication for Theracim

Indonesia’s FDA (BPOM) has approved new indication “Locally advanced non-nasopharyngeal...

READ MORE
card-img

Thailand FDA has approved Rituxikal (Rituximab Biosimilar)

On 11 May 2022, Thailand FDA has approved Rituxikal (Rituximab Biosimilar). By this milestone, ...

READ MORE
card-img

General Atlantic US Invests US$55 Million in Kalbe Genexine Biologics

General Atlantic, a leading worldwide growth equity firm that invests in and supports early-stage companies...

READ MORE